Patent commercialization · Industrial scale-up · Capital markets
Your patent deserves a factory. And a market.
We help patent owners turn proven technology into manufacturing businesses — structuring the IP, the plant, the capital and, when the time is right, the route to public markets.
Issuer-side advisory. Independent. Paid in part on outcomes.
The problem
Most patents never reach production. Not because the technology fails.
They stall between the pilot line and the first plant. That is where the capital need jumps from thousands to tens of millions, where investors ask for proof the inventor never had to produce, and where one wrong structure — in ownership, protection or financing — closes doors for years.
The gap is industrial, not intellectual.
Scaling a patent means a plant, certifications, suppliers and a team that can run them.
The capital is mixed, not single.
No single investor funds the whole path. Grants, incentives, debt, strategic partners and equity have to be stacked in the right order.
The structure decides the outcome.
Who owns the IP, where it is protected and how it is licensed determines who will invest — and at what price.
Approach
One path. Clear gates. No step skipped.
We work in stages. Each one ends with a measurable gate, so time and capital are only committed when the previous step is proven.
01
Assess
Is the patent investable? We review protection, freedom to operate, technology and manufacturing readiness, market and team.
Gate: a clear go / fix / stop verdict.
02
Structure
Clean ownership of the IP, the right holding and operating structure, a protection plan for the markets that matter, and the decision that shapes everything else: build, license or partner.
Gate: an investable company.
03
Industrialize
From pilot line to plant: business case, capex plan, site selection, certification path, supply chain and the industrial partners to execute it.
Gate: a bankable plant plan.
04
Capitalize
The capital stack for each stage: non-dilutive funding, public incentives, development and commercial debt, strategic partners and equity — prepared and coordinated with licensed partners.
Gate: funded milestones.
05
Scale globally
Licensing and joint ventures in new markets, export structures, strategic M&A and, for companies that reach the threshold, the route to public markets.
Gate: an exit or a listing that fits the business.
Services
Everything between the patent and the market.
01
Investability Assessment
A fixed-scope review of the patent, technology and manufacturing readiness, market, team and ownership. You receive a written verdict and a prioritized action list.
02
IP & Corporate Structuring
Chain of title, protection strategy (PCT, EP and key markets), freedom-to-operate coordination, holding and operating structure, cap table and incentive plans — delivered with specialist patent and legal partners.
03
Commercialization Strategy
Build, license or joint venture: a side-by-side economic comparison and the partner search that follows from it.
04
Industrial Scale-Up
Pilot-to-plant business case, capex and phasing plan, site and incentive analysis, certification roadmap, supplier and EPC coordination, owner-side oversight during construction.
05
Capital Strategy & Transaction Preparation
Capital stack design, grant and incentive applications, debt structuring support, investor materials, data rooms and negotiation support — as advisor to the company.
06
Capital Markets Readiness
Governance, reporting and audit readiness, route and venue selection, coordination of banks, sponsors, counsel and auditors through the transaction.
07
Board & Strategic Advisory
Ongoing advisory seat, KPI framework, finance function build-out and preparation for each next round.
Capital, structured
The right capital, in the right order.
Building a plant with equity alone is the most expensive way to scale. We design a capital stack that matches each source to the risk it is built to carry.
| Stage | Typical sources we help you prepare for |
|---|---|
| Prototype & validation | Innovation grants, technology-transfer programmes, angel and seed equity |
| Pilot line & certification | European innovation funding (grant and equity), seed and Series A, joint development agreements with industrial partners |
| First plant | Public investment incentives, development-bank and commercial debt, equipment leasing, offtake agreements, growth equity |
| International scale-up | Licensing and joint ventures, export credit support, growth equity, strategic M&A, public markets |
We act as advisor to the company. Where a transaction requires a licensed intermediary, we work alongside regulated banks, brokers and listing advisors.
Public markets
Public markets are a tool, not a trophy.
A listing makes sense when the business, the capital need and the investor base line up. We help you choose the route that fits — and tell you plainly when private capital or a strategic deal is the better answer.
IPO
A primary offering on a US exchange or a European growth market, chosen by deal size, sector depth and where your natural investors are.
De-SPAC
A combination with a listed acquisition company, with pricing agreed upfront and a committed investor base behind it.
Reverse merger
Entry into an existing listed company, used selectively and paired with fresh financing.
Dual listing
A European base with access to US liquidity, or the reverse, as the company grows.
Spin-off listing
A patent-driven division separated into its own listed company, while the parent keeps control.
What we do
Readiness (governance, reporting, audit), route and venue selection, selection and coordination of banks, sponsors, counsel and auditors, and support through the transaction and the first year as a listed company.
What we don't do
We do not underwrite, place or sell securities. Those roles are performed by licensed institutions.
Who we work with
Built for owners of patents that need to be manufactured.
- Inventors and founders with a working prototype and a granted or pending patent.
- Industrial companies with a patented technology outside their core business, ready to be spun out.
- Growth manufacturers scaling a proprietary process into new markets.
- Research institutions licensing or spinning out technology with industrial potential.
Our work is most effective from a proven prototype onwards (technology readiness level 6 and above).
How we work
Aligned with your outcome.
- 1.
Start with an assessment. A fixed fee and a fixed timeline. You keep the report whatever you decide.
- 2.
Agree a staged mandate. Each stage has its own scope, deliverables and gate. You never commit to the whole path upfront.
- 3.
Share the upside. Part of our compensation is tied to milestones and outcomes, so we win when you do.
- 4.
Bring in the specialists. Patent attorneys, engineers, auditors, lenders and licensed intermediaries join when their stage begins — coordinated by one team.
- 5.
Disclose every interest. Any relationship between us and a financing party is disclosed in writing before you sign anything.
Why Flavia IP Capital
One team from patent to market.
Industrial, not only financial.
We plan plants, certifications and supply chains, not just funding rounds.
Capital-stack thinking.
We start from the cheapest capital that fits the risk, and use equity where it creates the most value.
Honest about routes.
Licensing, a joint venture or a trade sale is often the better outcome. We say so.
Skin in the game.
Part of our compensation depends on your milestones.
A network across Europe, the US and the Gulf.
Engineers, patent counsel, lenders, strategic partners and licensed intermediaries, brought in at the right stage.
FAQ
Questions
Contact
Find out if your patent is ready to scale.
Start with an Investability Assessment: a fixed scope, a fixed fee and a clear verdict on what it will take to reach production and capital.